|
|
|
42
|
A831EV
|
APO-CELECOXIB 200MG CAP (APO)
|
CELECOXIB
|
APO-CELECOXIB
|
100'S
|
C
|
16.31
|
0.16
|
CAP
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A831EW
|
ETOVAN 60MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
3X10
|
C
|
14.33
|
0.48
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A831EX
|
ETOVAN 90MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
2X15
|
C
|
11.04
|
0.37
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2022-07-13
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A831EX
|
ETOVAN 90MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
2X15
|
C
|
16.55
|
0.55
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-07-14
|
2024-03-31
|
Price Change
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-07-13
|
|
|
|
40
|
A831EY
|
ETOVAN 120MG TAB (ARP/AHI) ETORICOXIB
|
ETORICOXIB
|
ETOVAN
|
2X10
|
C
|
11.04
|
0.55
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A831FM
|
APO-MELOXICAM 7.5MG TAB (APO) (C)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
4.62
|
0.0462
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FN
|
APO-MELOXICAM 15MG TAB (APO) (C)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
7.77
|
0.0777
|
TAB
|
15
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FT
|
CELECOXIB 200MG CAP (MCP) (C)
|
CELECOXIB
|
CELECOXIB
|
3X10
|
C
|
3.18
|
0.106
|
CAP
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FU
|
ETORICOXIB 120MG CAP (MCP) (C)
|
ETORICOXIB
|
ETORICOXIB
|
3X10
|
C
|
11.06
|
0.3688
|
CAP
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FV
|
ETORICOXIB 60MG CAP (MCP) (C)
|
ETORICOXIB
|
ETORICOXIB
|
3X10
|
C
|
4.27
|
0.1423
|
CAP
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FW
|
ETORICOXIB 90MG CAP (MCP) (C)
|
ETORICOXIB
|
ETORICOXIB
|
3X10
|
C
|
5.63
|
0.1876
|
CAP
|
0
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
A831GH
|
CELEBREX 200MG CAP (PFI) CELECOXIB
|
CELECOXIB
|
CELEBREX
|
30'S
|
C
|
54.96
|
1.83
|
CAP
|
0
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
COL
|
AVENTA BARBADOS
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
|
|
|
|
42
|
A911E
|
PEGEX 6MG INJ (EMC) PEGFILGRASTIM
|
PEGFILGRASTIM
|
PEGEX
|
0.6ML PFS
|
BQ
|
67.96
|
67.96
|
PFS
|
0
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
2016
|
HEMATOPOIETIC
|
2026-04-01
|
2028-03-31
|
|
SC
|
0
|
HEMATOPOIETIC
|
|
|
|
|
40
|
A911K
|
ZARZIO 300MCG INJ (BCH/COL) FILGRASTIM
|
FILGRASTIM
|
ZARZIO
|
5X300IU
|
BQ
|
217.47
|
43.49
|
INJECTION
|
0
|
PFS
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
A911K
|
ZARZIO 300MCG INJ (BCH) FILGRASTIM (BQ)
|
FILGRASTIM
|
ZARZIO
|
5X300IU
|
BQ
|
217.47
|
43.4932
|
PFS
|
15
|
BOX
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
2016
|
HEMATOPOIETIC
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HEMATOPOIETIC
|
|
|
|
|
42
|
A911K
|
ZARZIO 300MCG INJ (BCH) FILGRASTIM
|
FILGRASTIM
|
ZARZIO
|
5X300IU
|
BQ
|
217.47
|
43.49
|
PFS
|
15
|
BOX
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
2016
|
HEMATOPOIETIC
|
2026-04-01
|
2028-03-31
|
|
SC
|
0
|
HEMATOPOIETIC
|
|
|
|
|
40
|
A911S
|
PEG-GRAFEEL 6MG INJ (DRL/AAL) PEGFILGRASTIM
|
PEGFILGRASTIM
|
PEG-GRAFEEL
|
1 DS SYRNG
|
BQ
|
419.93
|
419.93
|
INJECTION
|
0
|
PFS
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
A911S
|
PEG-GRAFEEL 6MG INJ (DRL) PEGFILGRA (BQ)
|
PEGFILGRASTIM
|
PEG-GRAFEEL
|
1 DS SYRNG
|
BQ
|
380.57
|
380.5654
|
PFS
|
0
|
BOX
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
2016
|
HEMATOPOIETIC
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HEMATOPOIETIC
|
|
|
|
|
42
|
A911S
|
PEG-GRAFEEL 6MG INJ (DRL) PEGFILGRASTIM
|
PEGFILGRASTIM
|
PEG-GRAFEEL
|
6MG
|
BQ
|
304.45
|
304.45
|
PFS
|
0
|
BOX
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
2016
|
HEMATOPOIETIC
|
2026-04-01
|
2028-03-31
|
|
SC
|
0
|
HEMATOPOIETIC
|
|
|
|
|
40
|
A9416
|
FLOMAX MR 0.4MG TAB (BOE/STO) TAMSULOSIN MR
|
TAMSULOSIN MR
|
FLOMAX MR
|
30'S
|
C
|
47.14
|
1.57
|
TABLET
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
12160412
|
SELECTIVE ALPHA 1 ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
